Parkman Healthcare Partners

Overview

Parkman Healthcare Partners is a healthcare-focused investment firm specializing in biotechnology and pharmaceutical sectors. They leverage deep industry experience and intellectual curiosity to consistently protect and grow capital, seeking out innovations and opportunities globally across subsectors such as biotech, pharma, medical devices, diagnostics, life science research, and services. Their team is passionate about discovering healthcare advancements with significant growth potential, employing an evidence-based approach to create a dynamic portfolio that captures value inflection points in medicine as the standard of care evolves over time. The firm's investment strategy combines thematic growth investing with risk management and protection. They focus on small- and mid-cap companies, applying a rigorous fundamental research process to identify businesses at the forefront of innovation. Their unique process involves seeking out the future standard of care in medicine, identifying high-quality businesses with proven proof of concept, and discovering new innovations and technologies that can create substantial value. Additionally, they run a lower net strategy with active gross exposure management, diversify across subsectors, market caps, and geographies, and select appropriate position sizes given evolving industry dynamics. Parkman Healthcare Partners is 100% employee-owned, with team members committed to their culture, passionate about healthcare, and driven to deliver sustainable results for investors. The firm was founded in 2019 and has a team size of 1-10 employees.

Investment Focus

• Focus on small- and mid-cap companies
• Emphasis on biotechnology and pharmaceutical sectors
• Evidence-based approach to investment decisions
• Diversification across subsectors, market caps, and geographies
• Active risk management and protection strategies

Portfolio Companies